Population
112 Chinese patients with Takotsubo syndrome enrolled in the ChiTTS Registry from 02/01/2016 to 12/28/2021…
Design
Cohort
Follow-up
up to 3 years
Key result
Tachycardia in patients with Takotsubo syndrome was associated with a significantly higher risk of major adverse cardiovascular events over 3 years (HR 4.18; 95% CI 1.80-9.74; P<0.001).
Authors
Loading...
Tachycardia signals higher MACE risk in Takotsubo syndrome; hypothesis-generating and requires prospective validation before guiding care.
Observational (n=112)
Hazard Ratio: 4.18 (95% CI 1.8–9.74)
p-value: p=<0.001
In Chinese patients with Takotsubo syndrome, tachycardia is a strong predictor of adverse events, whereas beta-blocker therapy at discharge may be associated with improved long-term outcomes.
Chong et al. (2023) conducted an observational in Takotsubo syndrome (n=112). Tachycardia vs. Absence of tachycardia was evaluated on Major adverse cardiovascular and cerebrovascular events (MACCE) (HR 4.18, 95% CI 1.80-9.74, p=<0.001). Tachycardia in patients with Takotsubo syndrome was associated with a significantly higher risk of major adverse cardiovascular events over 3 years (HR 4.18; 95% CI 1.80-9.74; P<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: